Typicality: | 0.288 |
Saliency: | 0.447 |
for both the mother | 6 | transitive-object |
clinically | 2 | manner |
in previous clinical trials | 2 | location |
therapy → be proven to be → safe | 20 |
therapy → be shown to be → safe | 13 |
therapy → be proven → safe | 5 |
negative | neutral | positive |
0.070 | 0.425 | 0.505 |
Raw frequency | 38 |
Normalized frequency | 0.447 |
Modifier score | 0.300 |
Perplexity | 38.584 |